Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

[Intimate partner violence and depression among adult women working in a health facility in Mexico].

Guzmán-Rodríguez C, Cupul-Uicab LA, Guimarães Borges GL, Salazar-Martínez E, Salmerón J, Reynales-Shigematsu LM.

Gac Sanit. 2019 Nov 26. pii: S0213-9111(19)30230-4. doi: 10.1016/j.gaceta.2019.09.005. [Epub ahead of print] Spanish.

2.

Serum Proteomic Analysis Reveals Vitamin D-Binding Protein (VDBP) as a Potential Biomarker for Low Bone Mineral Density in Mexican Postmenopausal Women.

Martínez-Aguilar MM, Aparicio-Bautista DI, Ramírez-Salazar EG, Reyes-Grajeda JP, De la Cruz-Montoya AH, Antuna-Puente B, Hidalgo-Bravo A, Rivera-Paredez B, Ramírez-Palacios P, Quiterio M, Valdés-Flores M, Salmerón J, Velázquez-Cruz R.

Nutrients. 2019 Nov 21;11(12). pii: E2853. doi: 10.3390/nu11122853.

3.

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.

Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J; FRIDA Study Group.

JAMA Netw Open. 2019 Nov 1;2(11):e1915781. doi: 10.1001/jamanetworkopen.2019.15781.

PMID:
31747033
4.

Associations between dietary patterns and metabolic syndrome in adolescents.

Ramírez-López G, Flores-Aldana M, Salmerón J.

Salud Publica Mex. 2019 Sep-Oct;61(5):619-628. doi: 10.21149/9541.

PMID:
31661739
5.

Uptake of the HPV vaccine among people with and without HIV, cisgender and transgender women and men who have sex with men and with women at two sexual health clinics in Mexico City.

Allen-Leigh B, Rivera-Rivera L, Yunes-Díaz E, Portillo-Romero AJ, Brown B, León-Maldonado L, Vargas-Guadarrama G, Salmerón J, Lazcano-Ponce EC.

Hum Vaccin Immunother. 2019 Nov 1:1-10. doi: 10.1080/21645515.2019.1675456. [Epub ahead of print]

PMID:
31657665
6.

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.

Hernández-López R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, Ramírez-Palacios P, Lazcano-Ponce E, Cuzick J, Salmerón J; FRIDA Study Group.

Clin Epigenetics. 2019 Oct 12;11(1):140. doi: 10.1186/s13148-019-0743-9.

7.

Oral human papillomavirus prevalence and type distribution by country (Brazil, Mexico and the United States) and age among HPV infection in men study participants.

Bettampadi D, Villa LL, Ponce EL, Salmeron J, Sirak BA, Abrahamsen M, Rathwell JA, Reich RR, Giuliano AR.

Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32713. [Epub ahead of print]

PMID:
31583681
8.

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.

Rosillon D, Baril L, Del Rosario-Raymundo MR, Wheeler CM, Skinner SR, Garland SM, Salmeron J, Lazcano-Ponce E, Vallejos CS, Stoney T, Ter Harmsel B, Lim TYK, Quek SC, Minkina G, McNeil SA, Bouchard C, Fong KL, Money D, Ilancheran A, Savicheva A, Cruickshank M, Chatterjee A, Fiander A, Martens M, Bozonnat MC, Struyf F, Dubin G, Castellsagué X.

Cancer Med. 2019 Aug;8(10):4938-4953. doi: 10.1002/cam4.1879. Epub 2019 Jul 5.

9.

Influence of Genetic and Non-Genetic Risk Factors for Serum Uric Acid Levels and Hyperuricemia in Mexicans.

Rivera-Paredez B, Macías-Kauffer L, Fernandez-Lopez JC, Villalobos-Comparán M, Martinez-Aguilar MM, de la Cruz-Montoya A, Ramírez-Salazar EG, Villamil-Ramírez H, Quiterio M, Ramírez-Palacios P, Romero-Hidalgo S, Villarreal-Molina MT, Denova-Gutiérrez E, Flores YN, Canizales-Quinteros S, Salmerón J, Velázquez-Cruz R.

Nutrients. 2019 Jun 14;11(6). pii: E1336. doi: 10.3390/nu11061336.

10.

Increased Prevalence of Psychosocial, Behavioral, and Socio-Environmental Risk Factors among Overweight and Obese Youths in Mexico and the United States.

Flores YN, Contreras ZA, Ramírez-Palacios P, Morales LS, Edwards TC, Gallegos-Carrillo K, Salmerón J, Lang CM, Sportiche N, Patrick DL.

Int J Environ Res Public Health. 2019 Apr 30;16(9). pii: E1534. doi: 10.3390/ijerph16091534.

11.

HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men.

Parker KH, Kemp TJ, Isaacs-Soriano K, Abrahamsen M, Pan Y, Lazcano-Ponce E, Salmeron J, Pinto LA, Giuliano AR.

Vaccine. 2019 May 9;37(21):2864-2869. doi: 10.1016/j.vaccine.2019.03.064. Epub 2019 Apr 17.

PMID:
31005426
12.

Preventive health services and physical activity improve health-related quality of life in Mexican older adults.

Gallegos-Carrillo K, Honorato-Cabañas Y, Macías N, García-Peña C, Flores YN, Salmerón J.

Salud Publica Mex. 2019 Mar-Apr;61(2):106-115. doi: 10.21149/9400.

PMID:
30958953
13.

The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Nyitray AG, Peng F, Day RS, Carvalho Da Silva RJ, Baggio ML, Salmerón J, Quiterio M, Abrahamsen M, Lazcano-Ponce E, Villa LL, Giuliano AR.

Hum Vaccin Immunother. 2019;15(7-8):1911-1919. doi: 10.1080/21645515.2019.1593083. Epub 2019 Apr 19.

PMID:
30897017
14.

Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Granados-García V, Flores YN, Díaz-Trejo LI, Méndez-Sánchez L, Liu S, Salinas-Escudero G, Toledano-Toledano F, Salmerón J.

PLoS One. 2019 Feb 26;14(2):e0212558. doi: 10.1371/journal.pone.0212558. eCollection 2019.

15.

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.

Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, Luna-Gordillo R, Franco EL, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):722-733. doi: 10.21149/9891.

PMID:
30699277
16.

Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study.

Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR.

Salud Publica Mex. 2018 Nov-Dic;60(6):703-712. doi: 10.21149/10034.

PMID:
30699275
17.

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.

Lazcano-Ponce E, Carnalla-Cortés M, Barrientos-Gutiérrez T, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Hernández-Ávila M.

Salud Publica Mex. 2018 Nov-Dic;60(6):666-673. doi: 10.21149/10183.

PMID:
30699272
18.

HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV.

Portillo-Romero AJ, León-Maldonado L, Allen-Leigh B, Brown B, Magis C, García-Fuentes NB, Salmerón J, Hurtado E, Torres-Ibarra L, Rivera-Paredez B, Hernández-López R, Yunes-Díaz E, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):658-665. doi: 10.21149/10182.

PMID:
30699271
19.

Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies.

Posso H, León-Maldonado L, Allen-Leigh B, Salmerón J, Quiterio M, Giuliano AR, Sudenga SL, Nyitray AG, Torres BN, Abrahamsen M, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dec;60(6):645-652. doi: 10.21149/8454.

20.

Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.

Lazcano-Ponce E, Sudenga SL, Torres BN, Stoler M, León-Maldonado L, Allen-Leigh B, Posso H, Quiterio M, Hernández-Nevarez MDP, Salmerón J, Giuliano AR.

Salud Publica Mex. 2018 Nov-Dec;60(6):633-644. doi: 10.21149/8461.

Supplemental Content

Loading ...
Support Center